International Clinical Trial: A Single and Multiple Ascending Dose Study of JNJ-90858638 in Healthy Participants (Part 1 and 2: Single and Multiple Ascending Dose)

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ACTRN12625001434482) titled 'A Single and Multiple Ascending Dose Study of JNJ-90858638 in Healthy Participants (Part 1 and 2: Single and Multiple Ascending Dose)' on Dec. 17, 2025.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial

Primary Sponsor: Janssen Research & Development, LLC

Condition: Autoimmune Diseases Autoimmune Diseases Inflammatory and Immune System - Autoimmune diseases

Intervention: ARM:

Experimental: Part 1: Single Ascending Dose (SAD) Cohort

Participants will receive a single dose of JNJ-90858638 orally in a fasted or fed state. The high-fat, high-calorie meal w...